Get the Stockscreener App
4.23
2.67%
0.11
Sight Sciences Inc stock is traded at $4.23, with a volume of 227.91K.
It is up +2.67% in the last 24 hours and up +18.49% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$4.12
Open:
$4.15
24h Volume:
227.91K
Relative Volume:
1.56
Market Cap:
$221.51M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-3.7105
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
+0.71%
1M Performance:
+18.49%
6M Performance:
+67.19%
1Y Performance:
-33.07%
1-Day Range:
$4.115
$4.285
1-Week Range:
$4.02
$4.285
52-Week Range:
$2.03
$7.05
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.23 | 219.42M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Visualizing Sight Sciences Inc. stock with heatmapsAnalyst Downgrade & Free Reliable Trade Execution Plans - Newser
Developing predictive dashboards with Sight Sciences Inc. dataStop Loss & Verified Stock Trade Ideas - Newser
How high can Sight Sciences Inc. stock goMarket Performance Summary & Capital Protection Trade Alerts - Newser
How to use a screener to detect Sight Sciences Inc. breakoutsJuly 2025 Macro Moves & Free Expert Verified Stock Movement Alerts - Newser
Can volume confirm reversal in Sight Sciences Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
What moving averages say about Sight Sciences Inc.Product Launch & Safe Entry Point Alerts - Newser
Can swing trading help recover from Sight Sciences Inc. lossesWeekly Profit Report & AI Powered Market Trend Analysis - Newser
Sight Sciences Inc. Reaches Critical Trendline SupportTrade Risk Summary & Fast Entry Momentum Trade Alerts - newsimpact.co.kr
Sight Sciences Inc. Stock Recovery Path — Analyst Breakdown2025 Performance Recap & Daily Technical Stock Forecast Reports - classian.co.kr
Compared to Estimates, Sight Sciences (SGHT) Q2 Earnings: A Look at Key Metrics - MSN
What machine learning models say about Sight Sciences Inc.Entry Point & Consistent Growth Equity Picks - Newser
Real time breakdown of Sight Sciences Inc. stock performanceJuly 2025 Trends & Stepwise Trade Signal Implementation - Newser
How Sight Sciences Inc. stock performs during market volatilityQuarterly Portfolio Summary & Smart Swing Trading Alerts - Newser
Should I buy Sight Sciences Inc. stock before earnings2025 Performance Recap & AI Powered Buy and Sell Recommendations - Newser
Will Sight Sciences Inc. see short term momentumQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - Newser
Technical signs of recovery in Sight Sciences Inc.2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Analyzing Sight Sciences Inc. with risk reward ratio chartsQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Will Sight Sciences Inc. price bounce be sustainable2025 Volatility Report & Real-Time Market Trend Scan - Newser
Chart based exit strategy for Sight Sciences Inc.July 2025 Summary & Long-Term Growth Portfolio Plans - Newser
RSI Suggests Rebound May Be Near in Sight Sciences Inc.CPI Data & Momentum Based Trading Ideas - 선데이타임즈
Sight Sciences Inc. Approaches Support With Recovery in SightMarket Growth Report & AI Powered Market Trend Analysis - sundaytimes.kr
Sight Sciences’ Earnings Call: Balancing Growth and Challenges - TipRanks
Sight Sciences, Inc. (NASDAQ:SGHT) Q2 2025 Earnings Call Transcript - MSN
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of “Hold” by Brokerages - Defense World
Is Sight Sciences Inc. Stock a Good Fit for Conservative InvestorsEntry Optimization Guide with Volume Analysis - Newser
Sight Sciences, Inc. (NASDAQ:SGHT) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
Sight Sciences (SGHT) Stock Upgraded to 'Buy' with Raised Price Target by Lake Street - AInvest
Sight Sciences (NASDAQ:SGHT) Upgraded at Lake Street Capital - Defense World
Sight Sciences Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Sight Sciences (NASDAQ:SGHT) Raised to Hold at Wall Street Zen - Defense World
Will earnings trigger a reversal in Sight Sciences Inc.Free Conservative Long Term Growth Plans - Newser
Risk adjusted return profile for Sight Sciences Inc. analyzedPrice Action Trading with Volume Confirmation - Newser
Sector Leaders Rotate Capital Into Sight Sciences Inc.Community Shared Smart Money Signals Show Movement - metal.it
Sight Sciences raises 2025 revenue guidance to $72M–$76M amid strong OMNI growth and strategic focus on MIGS leadership - MSN
Does Sight Sciences (NASDAQ:SGHT) Have A Healthy Balance Sheet? - simplywall.st
A Quick Look at Today's Ratings for Sight Sciences(SGHT.US), With a Forecast Between $4 to $5 - 富途牛牛
QuinStreet: Lake Street lowers PT to $18 from $19, maintains Hold rating. - AInvest
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
Sight Sciences Reports Q2 EPS, Revenue Above Consensus, Glaucoma Ordering Accounts Reach New High - AInvest
Sight Sciences Raises FY25 Revenue Outlook to $72M-$76M, Reiterates Operating Expense Guidance of $101M-$105M. - AInvest
Sight Sciences stock rating upgraded by Lake Street on stabilizing business - Investing.com Nigeria
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sight Sciences Inc Stock (SGHT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| HAYDEN JEREMY B. | Chief Legal Officer |
Jul 03 '25 |
Sale |
4.17 |
9,160 |
38,234 |
266,321 |
| Bauerlein Alison | Chief Financial Officer |
Jul 02 '25 |
Sale |
4.10 |
19,260 |
78,927 |
617,468 |
| Badawi Paul | President and CEO |
Jul 01 '25 |
Sale |
4.15 |
23,637 |
98,141 |
5,986,943 |
| Badawi David | Chief Technology Officer |
Jul 03 '25 |
Sale |
4.17 |
5,679 |
23,704 |
1,831,025 |
| Link Matthew | Chief Commercial Officer |
Jul 02 '25 |
Sale |
4.10 |
4,889 |
20,035 |
832,293 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):